[Not Yet Scheduled]
Immunai's mission is to transform immunology by pioneering single-cell technologies coupled with the most cutting-edge AI methods. Immunai is a venture funded start-up headquartered in NYC.

Immunai's Scientific Advisory Board includes Dan Littman, Eran Segal, Regina Barzilai, Anshul Kundaje, and has strategic partnerships with some of the most prestigious oncology centers in the world.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Sr. Data Scientist
Parker Institute for Cancer Immunotherapy